Antares Pharma (ATRS)
|
3.76
0.00 (0.00%)
|
|
|
|
ATRS additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ATRS Profile
•
Exchange
NASDAQ
•
Sector
Not Available
•
Industry
Not Available
•
Top Holders (By Fund)
•
Executives
Dr. Paul K. Wotton Ph.D.
Chief Exec. Officer
Pres and Director
Mr. Robert F. Apple
Chief Financial Officer
Chief Accounting Officer Exec. VP Sec. and Pres of the Parenteral Products Division
Dr. Peter Sadowski Ph.D.
Chief Technology Officer and Sr. VP
Dr. Kaushik J. Dave Ph.D. Ph.
MBA. 50
Exec. VP of Product Devel.
Mr. Leroux Jooste r>Sr. VP of Pharmaceutical Sales and Marketing
Chief Exec. Officer
Pres and Director
Mr. Robert F. Apple
Chief Financial Officer
Chief Accounting Officer Exec. VP Sec. and Pres of the Parenteral Products Division
Dr. Peter Sadowski Ph.D.
Chief Technology Officer and Sr. VP
Dr. Kaushik J. Dave Ph.D. Ph.
MBA. 50
Exec. VP of Product Devel.
Mr. Leroux Jooste r>Sr. VP of Pharmaceutical Sales and Marketing
•
Employee Count
29
Special Offers
Competitors
ATRS earnings
Date
Actual
Expected
Prev Yr Qtr
11/7/2012
-0.03
-0.02
-0.01
8/8/2012
-0.03
-0.02
-0.02
